Elevance Health, Inc. (ELV)
NYSE
402.63
+2.09 (+0.52%)
Real-time Data
01:30 PM
Day's Range
398.32406.99
52 wk Range
274.84436.24
Financial Statements - ELV - Elevance Health, Inc.
Revenue
199.12B▲ 12.6%
Net Income
5.66B▼ 5.2%Net Margin 2.8%
Free Cash Flow
3.17B▼ 30.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 199.12B | 176.81B | 171.34B | 156.59B | 138.63B | 121.86B |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 24.47B | 22.63B | 19.45B | 14.97B | 12.65B | 10.38B |
| Pre Tax Income | 6.71B | 7.90B | 7.71B | 7.60B | 7.99B | 6.23B |
| Income Tax | 1.04B | 1.93B | 1.72B | 1.71B | 1.84B | 1.66B |
| Net Income | 5.66B | 5.97B | 5.99B | 5.88B | 6.14B | 4.57B |
| EPS Basic | 25.651957 | 26.288061 | 25.687442 | 25.319587 | 25.247058 | 18.630698 |
| EPS Diluted | 25.21 | 25.68 | 25.22 | 24.81 | 24.73 | 17.98 |
| Basic Shares Outstanding | 220.72M | 227.47M | 233.07M | 237.95M | 241.77M | 245.40M |
| Diluted Shares Outstanding | 220.72M | 227.47M | 233.07M | 237.95M | 241.77M | 245.40M |
| Ebit | 8.11B | 9.08B | 8.74B | 8.45B | 8.79B | 7.02B |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 5.66B | 5.97B | 5.99B | 5.88B | 6.14B | 4.57B |
| Minority Interests | 1M | 9M | -4M | 6M | 9M | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
